Dr. Benjamin Xu, M.D., Ph.D. received his B.S. from Yale University and M.D. and Ph.D. in neuroscience from Columbia University. He then completed his ophthalmology residency at the LAC+USC Medical Center / USC Roski Eye Institute and glaucoma fellowship at the UCSD Shiley Eye Institute under the mentorship of Dr. Robert N. Weinreb. He is now Chief of the Glaucoma Service at the USC Roski Eye Institute. His NIH-funded research focuses on developing new diagnostic tools to detect and care for patients with glaucoma using OCT imaging and artificial intelligence (AI). He also studies the impact of glaucoma on patient populations and healthcare systems worldwide using epidemiological and electronic healthcare data and devises new strategies to deliver more efficient and effective glaucoma care.
Dr. Benjamin Xu, M.D., Ph.D. received his B.S. from Yale University and M.D. and Ph.D. in neuroscience from Columbia University. He then completed his ophthalmology residency at the LAC+USC Medical Center / USC Roski Eye Institute and glaucoma fellowship at the UCSD Shiley Eye Institute under the mentorship of Dr. Robert N. Weinreb. He is now Chief of the Glaucoma Service at the USC Roski Eye Institute. His NIH-funded research focuses on developing new diagnostic tools to detect and care for patients with glaucoma using OCT imaging and artificial intelligence (AI). He also studies the impact of glaucoma on patient populations and healthcare systems worldwide using epidemiological and electronic healthcare data and devises new strategies to deliver more efficient and effective glaucoma care.